BrainAurora Medical Technology Limited (BRAINAURORA-B) submitted its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited on 02 June 2026, covering the month ended 31 May 2026. Key disclosures are as follows:

• Authorised share capital stayed unchanged at 500.00 billion ordinary shares with a par value of USD 0.0000001 each, amounting to total authorised capital of USD 50,000.

• Issued share capital remained steady at 1.36 billion ordinary shares. No new shares were issued, repurchased, or cancelled during the month, and the company continues to hold zero treasury shares.

• The company confirmed that it met the Main Board’s minimum public-float requirement of 25% as of 31 May 2026.

• No outstanding share options, warrants, convertible securities, or other equity-linked instruments were reported for the period.

The filing indicates that BRAINAURORA-B’s capital structure and share count were unchanged in May, and its free-float level remains compliant with Hong Kong listing rules.